PharmaLive: Barr Says Court Rejects Ciprofloxacin Antitrust Class Action Suits
PharmaLive: Barr Says Court Rejects Ciprofloxacin Antitrust Class Action Suits: "WOODCLIFF LAKE, N.J., March 31, 2005 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. today announced that the U.S. District Court for the Eastern District of New York has granted summary judgment in the Company's favor and rejected a challenge to the lawfulness of its 1997 settlement with Bayer Corporation of patent litigation related to the antibiotic Cipro(C). In his decision, the Honorable David Trager rejected the plaintiffs' claims that the 1997 settlement violated antitrust and consumer protection laws by delaying the entry of a generic version of Cipro. Judge Trager noted in his opinion that the settlement was not an unlawful restraint on trade, and instead allowed Barr to introduce a competing version of ciprofloxacin a year earlier than Bayer's Cipro patent otherwise would have permitted."
posted by Monkeyman @ 5:03 PM
0 Comments:
Post a Comment
<< Home